Maggie L. Shaw

Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.

She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.


Dr Amresh Raina on the Importance of Treating Dominant Disease Physiology in Comorbid HF

September 25, 2022

When mapping out treatment strategy, it is important to first establish dominant disease physiology in patients who have heart failure (HF) and pulmonary hypertension, explained Allegheny Health Network's Amresh Raina, MD.

Dr Hatim Husain Discusses HER2, Novel Therapy Exploration in Lung Cancer

September 23, 2022

During the Quality Cancer Care Alliance Summer 2022 National Leadership Summit, Hatim Husain, MD, discusses how HER2 exploration in lung cancer differs from that in breast cancer, as well as novel therapies being explored for HER2 and other disease targets.

Potential for Precision Medicine Approach in PAH Explored in New Study

September 16, 2022

This new study of pulmonary arterial hypertension (PAH) among women examined the in-common symptoms of different disease phenotypes to see where they overlap and ultimately to define the “symptome” according to symptom cluster and characteristics.

More Diversity, Multifaceted Outreach Needed in Studies of Genetic Screening for Depression

September 15, 2022

Three types of salient beliefs were investigated in this study that examined why mothers would or would not participate in depression screening via genetic salivary testing, with the results indicating potential for mental health disparities among diverse populations.

Risk Factors for CRS Plus Asthma Differ Among Younger vs Older Patients

September 14, 2022

Risk factors as predictors of asthma prevalence among a cohort of patients living with chronic rhinosinusitis (CRS), as they related to age, were evaluated by clinical investigators from the College of Medicine at Korea University.

Dr Anchalee Avihingsanon: We Can Learn About Curing Hepatitis B From Investigating HIV

September 10, 2022

Anchalee Avihingsanon, MD, PhD, HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand, is principal investigator of the ALLIANCE trial, currently evaluating the responses of treatment-naïve persons living with comorbid HIV/hepatitis B virus to a triplet regimen of bictegravir/emtricitabine/tenofovir alafenamide vs dolutegravir plus emtricitabine/tenofovir disoproxil fumarate.